Pasithea Therapeutics Corp.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
Mailing Address 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
Phone (702) 514-4174
Fiscal Year End 1231
EIN 851591963
Financial Overview
FY2024
-$13.90M
Net Income
$42.50M
Stockholders' Equity
$-0.42
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 15, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 8, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 5, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 5, 2025 | View on SEC |
| 8-K Current report of material events | December 2, 2025 | View on SEC |
| 4 Insider stock transaction report | December 1, 2025 | View on SEC |
| 4 Insider stock transaction report | December 1, 2025 | View on SEC |
Material Events
8-K Legal Issue December 15, 2025
High Impact
- Pasithea Therapeutics Corp. successfully resolved a major issue with the Nasdaq stock exchange.
- The company has officially regained compliance with Nasdaq's minimum bid price rule ($1.00 per share).
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.